STOCK TITAN

PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2020 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

PTC Therapeutics, Inc. (NASDAQ: PTCT) will host a conference call on August 5, 2020, at 4:30 p.m. ET to report its Q2 2020 financial results and business outlook. Investors can join the call by dialing (877) 303-9216 domestically or (973) 935-8152 internationally and using passcode 5897698. A live webcast will also be available on the company's website. PTC focuses on developing and commercializing innovative medicines for rare disorders and aims to provide access to transformative treatments for patients with unmet medical needs.

Positive
  • Focused on discovery and commercialization of innovative medicines for rare disorders.
  • Strong mission to provide access to best-in-class treatments.
Negative
  • None.

SOUTH PLAINFIELD, N.J., July 22, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its second quarter 2020 financial results and provide an update on the company's business and outlook on Wednesday, August 5, 2020 at 4:30 p.m. (ET) after the closing of the market.

The call can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152 (international) five minutes prior to the start of the call and providing the passcode 5897698. A live, listen-only webcast of the conference call can be accessed on the investor relations section of the PTC website at www.ptcbio.com. A webcast replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days following the call.

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.

FOR MORE INFORMATION PLEASE CONTACT:

Media:                             

Investors:

Jane Baj                           

Alex Kane

+1 (908) 912-9167             

+1 (908) 912-9643

jbaj@ptcbio.com                       

akane@ptcbio.com  

"Cision" View original content:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss-second-quarter-2020-financial-results-301096391.html

SOURCE PTC Therapeutics, Inc.

FAQ

What time will PTC Therapeutics announce its Q2 2020 financial results?

PTC Therapeutics will announce its Q2 2020 financial results on August 5, 2020, at 4:30 p.m. ET.

How can I access the PTC Therapeutics conference call?

You can access the PTC Therapeutics conference call by dialing (877) 303-9216 for domestic calls or (973) 935-8152 for international calls, and providing passcode 5897698.

Where can I find the webcast of the PTC Therapeutics conference call?

The live webcast of the PTC Therapeutics conference call will be available on the investor relations section of their website.

What is the focus of PTC Therapeutics?

PTC Therapeutics is focused on the discovery, development, and commercialization of clinically differentiated medicines for patients with rare disorders.

PTC Therapeutics, Inc.

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Stock Data

3.39B
77.13M
2.34%
105.79%
6.06%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
WARREN